Received May 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | x2tc2 | IM / LA |
Systemic: Fainting / Unresponsive-Medium, Systemic: Shakiness-Medium, Additional Details: Pt stated hx of dizziness or fainting with prior vaccine. Pt was instructed to remain seated in vaccine area for 10-15 minutes after vaccine administration for monitoring.